Characterization of histamine H3 receptors in Alzheimer's Disease brain and amyloid over‐expressing TASTPM mice
Open Access
- 8 April 2009
- journal article
- research article
- Published by Wiley in British Journal of Pharmacology
- Vol. 157 (1), 130-138
- https://doi.org/10.1111/j.1476-5381.2008.00075.x
Abstract
Background and purpose: Histamine H3 receptor antagonists are currently being evaluated for their potential use in a number of central nervous system disorders including Alzheimer's Disease (AD). To date, little is known about the state of H3 receptors in AD. Experimental approach: In the present study we used the radiolabelled H3 receptor antagonist [3H]GSK189254 to investigate H3 receptor binding in the amyloid over‐expressing double mutant APPswe × PSI.MI46V (TASTPM) transgenic mouse model of AD and in post‐mortem human AD brain samples. Key results: No significant differences in specific H3 receptor binding were observed between wild type and TASTPM mice in the cortex, hippocampus or hypothalamus. Specific [3H]GSK189254 binding was detected in sections of human medial frontal cortex from AD brains of varying disease severity (Braak stages I–VI). With more quantitative analysis in a larger cohort, we observed that H3 receptor densities were not significantly different between AD and age‐matched control brains in both frontal and temporal cortical regions. However, within the AD group, [3H]GSK189254 binding density in frontal cortex was higher in individuals with more severe dementia prior to death. Conclusions and implications: The maintenance of H3 receptor integrity observed in the various stages of AD in this study is important, given the potential use of H3 antagonists as a novel therapeutic approach for the symptomatic treatment of AD.Keywords
This publication has 43 references indexed in Scilit:
- The histamine H3 receptor: an attractive target for the treatment of cognitive disordersBritish Journal of Pharmacology, 2008
- Guide to Receptors and Channels (GRAC), 3rd editionBritish Journal of Pharmacology, 2008
- Acute wake‐promoting actions of JNJ‐5207852, a novel, diamine‐based H3 antagonistBritish Journal of Pharmacology, 2004
- Perspectives on cognitive domains, H3receptor ligands and neurological diseaseExpert Opinion on Investigational Drugs, 2004
- Natural history of behavioural changes and psychiatric symptoms in Alzheimer's diseaseThe British Journal of Psychiatry, 1999
- Clinical neurochemistry: developments in dementia research based on brain bank materialJournal of Neural Transmission, 1998
- Neuropathological stageing of Alzheimer-related changesActa Neuropathologica, 1991
- Analysis of radioligand binding experiments: A collection of computer programs for the IBM PCJournal of Pharmacological Methods, 1985
- The Cholinergic Hypothesis of Geriatric Memory DysfunctionScience, 1982
- Alzheimer's Disease and Senile Dementia: Loss of Neurons in the Basal ForebrainScience, 1982